Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
---|
04/21/2004 | CN1490056A Immune method and composition for HIV-1 |
04/21/2004 | CN1490016A Bougie for treating virus hepatitis and preparing method thereof |
04/21/2004 | CN1146429C Phospholipid complexes of proanthocyanidin A2 used as antiatherosclerotic agent |
04/21/2004 | CN1146427C Solid oral dosage form comprising combination of metformin and glibenclamide |
04/21/2004 | CN1146410C Controlled release formulation |
04/21/2004 | CN1146394C Dual component dentifrice composition for dental fluoridation |
04/20/2004 | US6723726 Protein tyrosine kinase inhibitors |
04/20/2004 | US6723719 Dysmenorrhoea, benign prostatic hyperplasia (bph), bladder outlet obstruction, incontinence, agina, congestive heart failure, atherosclerosis; hypotensive and antiallergen agents |
04/15/2004 | WO2004031356A2 Recombinant intracellular pathogen immunogenic compositions and methods for use |
04/15/2004 | WO2004030636A2 Human papillomavirus polypeptides and immunogenic compositions |
04/15/2004 | WO2004030634A2 Therapeutic compositions |
04/15/2004 | WO2004030631A2 Anti-cancer and anti-infectious disease compositions and methods for using same |
04/15/2004 | WO2004030623A2 Nitroxide radioprotector formulations and methods of use |
04/15/2004 | WO2004030622A2 Method of isolation and self-assembly of small protein particles from blood and other biological materials |
04/15/2004 | WO2004030614A2 Vaccines containing viruses involved in avian malabsorption syndrome and methods of administration therefor |
04/15/2004 | WO2004030612A2 Light emitting diode, support & method of manufacture |
04/15/2004 | WO2004030457A1 Nodulisporic acid derivative spot-on formulations for combating parasites |
04/15/2004 | WO2003043580A3 Methods for identifying and validating potential drug targets |
04/15/2004 | WO2003028527A8 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
04/15/2004 | WO2002061052A8 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
04/15/2004 | US20040072894 Anticholesterol agents; compressed into tablets |
04/15/2004 | US20040072891 Urogenital disorders |
04/15/2004 | US20040072880 Cycloalkyl inhibitors of potassium channel function |
04/15/2004 | US20040072831 Reverse-turn mimetics and method relating thereto |
04/15/2004 | US20040072748 Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections |
04/15/2004 | US20040072188 Comprises nucleotide sequences coding B-cell activating factor receptor (BAFF-R) for diagnosis, prevention, treatment and/or delay of cancers, lymphomas and autoimmune diseases |
04/15/2004 | US20040072152 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides |
04/15/2004 | US20040072138 Attenuation of ischemia/reperfusion injury |
04/15/2004 | US20040071767 NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
04/15/2004 | US20040071693 Humanised antibodies |
04/15/2004 | US20040071658 Vaccine immunotherapy for immune suppressed patients |
04/15/2004 | CA2501981A1 Nitroxide radioprotector formulations and methods of use |
04/15/2004 | CA2500822A1 Nodulisporic acid derivative spot-on formulations for combating parasites |
04/15/2004 | CA2500661A1 Anti-cancer and anti-infectious disease compositions and methods for using same |
04/15/2004 | CA2500433A1 Recombinant intracellular pathogen immunogenic compositions and methods for use |
04/15/2004 | CA2499837A1 Human papillomavirus polypeptides and immunogenic compositions |
04/15/2004 | CA2498823A1 Vaccines containing viruses involved in avian malabsorption syndrome and methods of administration therefor |
04/14/2004 | EP1407008A2 Influenza vaccine composition |
04/14/2004 | EP1406873A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
04/14/2004 | EP1406870A1 Taxol enhancer compounds |
04/14/2004 | EP1406869A1 Taxol enhancer compounds |
04/14/2004 | EP1406662A1 Pharmaceutical formulation for the intramuscular administration of fulvestrant |
04/14/2004 | EP1028110B1 Novel dihydronaphthalene compounds and process for producing the same |
04/14/2004 | EP0927040B1 Process to obtain oestrogens from mare's urine |
04/14/2004 | EP0724561B1 Calcium receptor-active arylalkyl amines |
04/14/2004 | CN1489592A 3,7-diazabicyclo[3,3,o] otanes and their use in treatment of cardiac arrhythmias |
04/14/2004 | CN1489590A Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof |
04/14/2004 | CN1489588A Thiazolyl-oxazolyl-pyrrolyl-and imidazolyl-acid amide derivatives useful as inbibitors of PDE 4 isozymes |
04/14/2004 | CN1489472A Improved mycoplasma hyopneumoniae bacterin vaccine |
04/14/2004 | CN1488353A Composition for treating ischemic disease |
04/14/2004 | CN1145643C Oligosaccharide mixtures having antithrombotic activity |
04/14/2004 | CN1145486C Pharmaceutical compositions containing eletriptan hemisulphate and coffeine |
04/14/2004 | CN1145478C Pharmaceutical aerosol formulation |
04/14/2004 | CN1145473C Keratin fibers oxidation dyeing composition and dyeing method using same |
04/13/2004 | US6720336 4,4-biarylpiperidine derivatives |
04/13/2004 | US6720009 Matrix protein compositions for treating infection |
04/08/2004 | WO2004029034A1 Synthesis of thiophenecarboxylic acid esters for the production of ranelic acid salts |
04/08/2004 | WO2004028521A2 Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders |
04/08/2004 | WO2004028509A1 Sustained released delivery of amphetamine salts |
04/08/2004 | WO2004028481A2 Nucleoside derivatives for treating hepatitis c virus infection |
04/08/2004 | WO2004028479A2 Nouvelles compositions et methodes de traitement du psoriasis |
04/08/2004 | WO2004028478A2 Functional mutations in respiratory syncytial virus |
04/08/2004 | WO2004028476A2 Artemisinin-derived trioxane dimers |
04/08/2004 | WO2004028473A2 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
04/08/2004 | WO2004028472A2 THERAPIES FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING INTERFERON-β |
04/08/2004 | WO2004028466A2 Ketoamide inhibitors in chronic nerve disease |
04/08/2004 | WO2004028464A2 Methods and compositions for modification of splicing of pre-mrna |
04/08/2004 | WO2004028463A2 Methods and compositions for the treatment of lupus using clofarabine |
04/08/2004 | WO2004028460A2 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
04/08/2004 | WO2004028458A2 Antisense modulation of microsomal prostaglandin e2 synthase expression |
04/08/2004 | WO2004028452A2 Method for preparing crambescidin core acid intermediates and their use for preparing crambescidin alkaloid analogs as therapeutic agents |
04/08/2004 | WO2004028444A2 Parathyroid hormone antagonists and uses thereof |
04/08/2004 | WO2004012658A3 Method and device for protein delivery into cells |
04/08/2004 | WO2004000205A3 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
04/08/2004 | WO2003022123A9 Methods of kidney transplantation utilizing developing nephric tissue |
04/08/2004 | US20040067940 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease |
04/08/2004 | US20040067921 Anticholesterol agents |
04/08/2004 | US20040067875 Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use |
04/08/2004 | US20040067245 Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin |
04/08/2004 | US20040067235 Methods for the use of neurotoxin in the treatment of urologic disorders |
04/08/2004 | CA2503510A1 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
04/08/2004 | CA2500189A1 Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-.beta. |
04/08/2004 | CA2500091A1 Methods and compositions for the treatment of lupus using clofarabine |
04/08/2004 | CA2499880A1 Methods and compositions for modification of splicing of pre-mrna |
04/08/2004 | CA2499843A1 Novel compositions and methods for the treatment of psoriasis |
04/08/2004 | CA2499253A1 Nucleoside derivatives for treating hepatitis c virus infection |
04/08/2004 | CA2499042A1 Functional mutations in respiratory syncytial virus |
04/08/2004 | CA2498483A1 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
04/07/2004 | EP1405852A1 Diamine derivatives |
04/07/2004 | EP1404667A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
04/07/2004 | EP1404651A1 Process for the preparation 3-aryl-2-hydroxypropionic acid derivative |
04/07/2004 | EP1404345A2 Skin-permeable selective cyclooxygenase-2 inhibitor composition |
04/07/2004 | EP1404309A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3- 4-(2- 4-methane sulfonyl oxyphenyl ethoxy) phenyl] propanoic acid or 3- 4- 2- (4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl -(s)-2-ethoxy propanoic acid and a biguanide drug |
04/07/2004 | EP1150991B1 Compositions for treating inflammatory response |
04/07/2004 | EP1052997B1 Compositions comprising d-chiro-inositol for treating metabolic diseases characterized by hyperandrogenism and/or anovulation |
04/07/2004 | EP0596032B2 Induction of cytotoxic t-lymphocyte responses |
04/07/2004 | CN1487933A Pyrazole compounds useful as protein kinase inhibitors |
04/07/2004 | CN1486698A Solid oral preparation containing melbine and Glibenclamide |
04/07/2004 | CN1144805C Bridged bispidine compounds, its preparing method and intermediate and use for treatment of cardiac arrhythmias |
04/06/2004 | US6716446 Medicament against dysmenorrhoea and premenstrual syndrome |